This collection brings together a focused selection of L.E.K. Consulting’s perspectives on the forces reshaping life sciences and biopharma. Across research, development and commercialization, companies are operating in a more demanding environment defined by rising scientific complexity, tighter capital discipline, increasing competition and higher expectation from patients regulators and investors. The articles in this booklet examine those pressures from multiple angles and offer practical guidance for leaders seeking to make better strategic choices in a period of rapid change.
Our insights highlight several of the issues now most relevant to industry decision makers. They look at how companies can raise R&D productivity and sharpen portfolio choices, how they can capture the next wave of revenue growth from both existing and future assets, how they can translate strategy into commercial impact through more targeted go-to-market models. They also address the operational and strategic implications of emerging technologies, which has the potential to reshape how innovation is developed, launched and scaled. Across these topics, a consistent message emerges: competitive advantage will increasingly belong to organisations that combine scientific ambition with disciplined decision—making and operational focus.
At L.E.K., we help clients interpret change and convert it into decisive action. By distilling market signals, emerging opportunities and the pressure points that matter most, this collection offers leaders a clear view of what it takes to steer successfully through a period of structural shifts.
For further insights into our analysis, download the full booklet.
L.E.K. Consulting is a registered trademark of L.E.K. Consulting LLC. All other products and brands mentioned in this document are properties of their respective owners. © 2026 L.E.K. Consulting LLC
